New scan could revolutionize prostate cancer monitoring
NCT ID NCT07553780
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a special type of scan called PSMA PET can better monitor how prostate cancer responds to treatment. Researchers will scan 110 men with high-risk prostate cancer before and after treatment to see if changes in the scan match standard measures like PSA levels. The goal is to find a more accurate way to guide treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PSMA PET/CT imaging
- What this could lead to
- If successful, this could provide a more accurate way to monitor treatment response in prostate cancer, potentially guiding better treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It may not show clear benefits, and results might not change current practices.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Yan'an University
RECRUITINGYan’an, Shaanxi, China
-
General Hospital of Ningxia Medical University
RECRUITINGYinchuan, Ningxia, China
-
Qinghai University Affiliated Hospital
RECRUITINGXining, Qinghai, China
-
Shaanxi Provincial People's Hospital
RECRUITINGXi'an, Shaanxi, China
-
The First Hospital of Lanzhou University
RECRUITINGLanzhou, Gansu, China
-
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
RECRUITINGXianyang, Shaanxi, China
-
Weinan Central Hospital
RECRUITINGWeinan, Shaanxi, China
-
Xijing 986 Hospital
RECRUITINGXi'an, Shaanxi, China
-
Xijing Hospital
RECRUITINGXi'an, Shaanxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Man's best friend as cancer detector: can dogs sniff out prostate cancer?
- Can a single radiation type spare prostate cancer patients from extra side effects?
- New scan could reveal hidden cancer in High-Risk prostate patients
- Simple blood test could spare prostate cancer patients from unnecessary scans
- Promising prostate cancer combo trial pulled before starting
- New immunotherapy combo targets High-Risk prostate cancer before and after surgery